Published in Obesity and Diabetes Week, July 25th, 2005
"Long-term type 2 diabetes can lead to numerous biological complications, such as hypertension and cardiovascular disease. Key enzymes involved in the enzymatic breakdown of complex carbohydrates, pancreatic alpha-amylase and intestinal alpha-glucosidase, have been targeted as potential avenues for modulation of type 2 diabetes-associated postprandial hyperglycemia through mild inhibition of their enzymatic activities so as to decrease meal-derived glucose absorption.
"Further, inhibition of hypertension-linked angiotensin I-converting enzyme (ACE)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.